Number of the records: 1
vakcíny protinádorové
SYS d019496 LBL 00000cz--a2200000n--4500 005 20250606213714.6 008 960613|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 065 $a D20.215.894.200 066 $a 01 $c 03 150 $a vakcíny protinádorové $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Cancer Vaccine $2 eng 450 $w v $a Neoplasm Vaccines $2 eng 450 $w v $a Tumor Vaccine $2 eng 450 $w v $a Tumor Vaccines $2 eng 450 $w v $a Vaccines, Cancer $2 eng 450 $w v $a Vaccines, Neoplasm $2 eng 450 $w v $a Vaccines, Tumor $2 eng 450 $w v $a vakcína protinádorová $2 slo 450 $w v $a vakcíny nádorové $2 slo 450 $w v $a vakcíny proti nádorom $2 slo 550 $7 sllk_us_auth*d053918 $Y Papillomavirus Vaccines $w b $a vakcíny papilomavírusové 665 $a 97 $2 eng 665 $a Vaccines (1971-1996) $2 eng 680 9-
$i Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced. $2 eng 680 $a coord IM with specific cancer histol type (IM) + organ/neopl precoord (IM) $2 eng 750 -2
$a Cancer Vaccines $2 eng 980 $x M
Number of the records: 1